Supernus Pharmaceuticals, Inc. · NASDAQ:SUPN
Mottola Frank exercised options for 1,650 Supernus Pharmaceuticals, Inc. shares (Form 4)
Traded Aug 12, 2026 · Filed Aug 14, 2026
On Aug 12, 2026, Mottola Frank (SVP, Chief Tech. Ops. Officer) exercised options for 1,650 Supernus Pharmaceuticals, Inc. shares, leaving 19,544 shares. Filed Aug 14, 2026 (Form 4).
- Options exercised
- 1,650 shares
- Holding after
- 19,544 shares
- Trading plan
- No
- Role
- SVP, Chief Tech. Ops. Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | Option exercise | 1,650 | 20,341 | Direct | |
| Aug 12, 2026 | Common Stock | Shares withheld for tax | 797 | US$46.57 | 19,544 | Direct |